Moreover, a retrospective study of 83 tumours revealed that only two alterations were uniformly associated with high grade and advanced stage of a tumour [21]: TP53/MDM2 alterations, which were associated with poor prognosis, and FGFR3 mutations, which were associated with more favourable outcome. The gene discussed is TP53; the disease is neoplasm.